Аннотация:
Introduction: The metabolic alterations reflecting the influence of prostate cancer cells can be captured through metabolomic profiling. Objective: To characterize the plasma metabolomic profile in prostatic intraepithelial neoplasia (PIN) and prostate cancer (PCa). Methods: Metabolomics analyses were performed in plasma samples from individuals classified as non-cancerous control (n = 36), with PIN (n = 16), or PCa (n = 27). Untargeted [26 moieties identified after pre-processing by gas chromatography/mass spectrometry (GC/MS)] and targeted [46 amino acids, carbohydrates, organic acids and fatty acids by GC/MS, and 16 nucleosides and amino acids by ultra performance liquid chromatography-triple quadrupole/mass spectrometry (UPLC-TQ/MS)] analyses were performed. Prostate specific antigen (PSA) concentrations were measured in all samples. In PCa patients, the Gleason scores were determined. Results: The metabolites that were best discriminated (p < 0.05, FDR < 0.2) for the Kruskal–Walli
Markin P. A. Pavel Aleksandrovich 1996-
Brito O. A. A. Olivares Aleks Al`berto 1982-
Moskaleva N. E. Natal`ya Evgenyevna 1971-
Lartsova E. V. Ekaterina Viktorovna 1985-
Shpot Y. V.
Lerner Yu. V. Yuliya Vladimirovna 1981-
Mikhajlov V. Y.
Potoldy'kova N. V. Natal`ya Valerievna 1982-
Enikeev D. V. Dmitrij Viktorovich 1982-
La F. M. R. Frano M.R.
Appolonova S. A. Svetlana Aleksandrovna 1973-
Маркин П. А. Павел Александрович 1996-
Брито О. А. А. Оливарес Алекс Альберто 1982-
Москалева Н. Е. Наталья Евгеньевна 1971-
Ларцова Е. В. Екатерина Викторовна 1985-
Шпот Y. В.
Лернер Ю. В. Юлия Владимировна 1981-
Михайлов В. Y.
Потолдыкова Н. В. Наталья Валериевна 1982-
Еникеев Д. В. Дмитрий Викторович 1982-
Ла Ф. М. Р. Франо М.Р.
Апполонова С. А. Светлана Александровна 1973-
Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score
Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the...
Текст визуальный непосредственный
Metabolomics
Springer Science+Business Media Inc., Formerly Kluwer Boston Inc
Vol.16, Issue7 Num.74
2020
Статья
Gas chromatography/mass spectrometry Metabolome Metabolomics Prostate cancer Ultra performance liquid chromatography-triple quadrupole/mass spectrometry
prostate specific antigen adenocarcinoma in situ amino acid composition amino acid metabolism Article disease activity Gleason score high performance liquid chromatography hormone synthesis human lipid metabolism liquid chromatography-mass spectrometry mass fragmentography mass spectrometry metabolic fingerprinting metabolomics principal component analysis prostate cancer receiver operating characteristic sensitivity and specificity ultra performance liquid chromatography
Introduction: The metabolic alterations reflecting the influence of prostate cancer cells can be captured through metabolomic profiling. Objective: To characterize the plasma metabolomic profile in prostatic intraepithelial neoplasia (PIN) and prostate cancer (PCa). Methods: Metabolomics analyses were performed in plasma samples from individuals classified as non-cancerous control (n = 36), with PIN (n = 16), or PCa (n = 27). Untargeted [26 moieties identified after pre-processing by gas chromatography/mass spectrometry (GC/MS)] and targeted [46 amino acids, carbohydrates, organic acids and fatty acids by GC/MS, and 16 nucleosides and amino acids by ultra performance liquid chromatography-triple quadrupole/mass spectrometry (UPLC-TQ/MS)] analyses were performed. Prostate specific antigen (PSA) concentrations were measured in all samples. In PCa patients, the Gleason scores were determined. Results: The metabolites that were best discriminated (p < 0.05, FDR < 0.2) for the Kruskal–Walli